FamW. M.McGregorH.: Effect of Coronary Vasodilator Drugs on Retrograde Flow in Areas of Chronic Myocardial Ischemia, Circ. Res.15: 355, 1964.
12.
HoeschenR. J.: Hemodynamic Effects of Angina and Nitroglycerin in Normal and Anginal Subjects, Brit. Heart J.28: 222, 1966.
13.
ContiC. R.: Myocardial Blood Flow in Pacing - Induced Angina Pectoris, 42: 815, 1970.
14.
MasonD. T.BraunwaldE.E.: The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm, Circulation32: 755–771, 1965.
15.
WilliamsJ. F.: Studies on Cardiac Dimensions in Intact Unanesthetized Man. V. Effects of Nitroglycerin, Circulation32: 767–771, 1965.
16.
SampsonJ. J.HyattK. H.: Management of the Patient with Severe Angina Pectoris, Circulation46: 1185, 1972.
17.
AronowW. S.: Management of Stable Angina, New Engl. J. Med.289: 516 (10) 1973.
AaronH.: Disintegration and Storage of Nitroglycerin Tablets, Med. Letter Drug Ther.13: 13, 1971.
20.
JohnsonE. M.: Clearance and Metabolism of Organic Nitrates, J. Pharmacol. Exp. Ther.182: 56–62, July 1972.
21.
RusserH.: Therapeutic Role of Coronary Vasodilatation: Glyceryl Dinitrate, Isosorbide Dinitrate and Pentaerythritol Tetranitrate, Amer. J. Med.252: 9, 1966.
22.
BunnW. H.Jr.ChremosA. N.: Clinical Evaluation of Sublingual Nitrates: Onset and Duration of Nitroglycerin and Isosorbide Dinitrate, Angiology14: 48, 1963.
23.
AronowW. S.ChesluckH. M.: Evaluation of Nitroglycerin in Angina in Patients on Isosorbide Dinitrate, Circulation42: 61, 1970.
GoldsteinR. E.: Clinical and Circulatory Effects of Isosorbide Dinitrate: Comparison with Nitroglycerin, Circulaton43: 629, 1971.
26.
StibeA. A.FinkG. B.: Prophylactic Therapy of Angina Pectoris with Organic Nitrates: Relationship of Drug Efficacy and Clinical Experimental Design, J. Clin. Pharmacol.13: 244 (July) 1973.
27.
DavisT. A.WieselB. H.: The Treatment of Angina Pectoris with Nitroglycerin Ointment, Amer J. Med. Sci.230: 259, 1955.
28.
Needleman: Organic Nitrates: Relationship between Biotransformation and Rational Angina Pectoris Therapy, J. Pharmacol Exp. Ther.181: 489–497, 1972.
29.
BattockD. J.: Effects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina Pectoris, Circulation39: 157, 1969.
30.
WeinerL. E. M.: Hemodynamic Effects of Nitroglycerin, Propranolol and Their Combination in Coronary Heart Disease, Circulation39: 623, 1969.
31.
GoldbergA. N.: Therapy of Angina Pectoris with Propranolol and Long Acting-Nitrites, Circulation40: 487, 1969.
32.
GoldsteinR. G.EpsteinS. E.: Nitrates in the Prophylactic Treatment of Angina Pectoris, Circulation48: 917–920, 1973.
33.
FDA Drug Bulletin, January 1974.
34.
BraunwaldE.: Editorial: Symposium on Beta Adrenergic Receptor Blockade, Amer. J. Cardiol.18: 303, 1966.
35.
WolfsonS.GorlinR.: Cardiovascular Pharmacology of Propranolol in Man, Circulation40: 501, 1969.
36.
AronowW. S.: The Medical Treatment of Angina Pectoris, VI. Propranolol as an Antianginal Drug, Amer. Heart J.84: 706–709 (5) 1972.
37.
ScrivastauaS. C.: Double Blind Trial of Propranolol (Inderal) in Angina of Effect, Brit. Med. J.2: 274, 1964.
38.
AldermanE. L.: Dose-response Effectiveness of Propranolol for the Treatment of Angina Pectoris, Abstract, Amer. J. Cardiology33: 122 (Jan.) 1974.
39.
ZeftH. J.: The Effect of Propranolol in the long-term Treatment of Angina Pectoris, Arch. Intern. Med.124: 588, 1969.
40.
FaulknerS. L.: Time Required for Complete Recovery from Chronic Propranolol Therapy, N. Engl. J. Med.289: 607–609, 1973.
41.
ColtartD. J.: Determination of the Safe Period for Withdrawal of Propranolol Therapy, Circulation7Suppl. IV: IV-7, 1973.
42.
GoicoecheaF. J.: Myocardial Infarction Complicated by Arrhythmias, Drug Intelligence Clin. Pharm.7: 120 (Mar.) 1973.
43.
ReicherN.: Sustained Effects of Nitroglycerin Ointment in Patients with Angina Pectoris, Amer. J. Cardiol.31: 153, 1972.